Skip to main navigation menu Skip to main content Skip to site footer

An Approach To:

Vol. 21 No. 1 (2023)

Approach to: Elevated Intraocular Pressure

October 13, 2022


N/A ("Approach to" article type)


  1. Nuzzi R, Marolo P, Nuzzi A. The Hub-and-Spoke Management of Glaucoma. Front Neurosci. 2020 Mar 17;14:180.
  2. Heijl, A., Leske, M. C., Bengtsson, B., Hyman, L., Bengtsson, B., Hussein, M., & Early Manifest Glaucoma Trial Group. (2002). Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of ophthalmology, 120(10), 1268-1279.
  3. Nongpiur ME, Ku JYF, Aung T. Angle closure glaucoma: a mechanistic review. Curr Opin Ophthalmol [Internet]. 2011 Mar [cited 2022 Sep 27];22(2):96–101. Available from:
  4. McMonnies CW. Glaucoma history and risk factors. J Optom [Internet]. 2017 Apr 1 [cited 2022 Sep 27];10(2):71. Available from: /pmc/articles/PMC5383456/
  5. Paranhos A. J, Paranhos FRL, Prata J, Omi CA, Mello PAA, Bruce Shields M. Influence of keratometric readings on comparative intraocular pressure measurements with Goldmann, Tono-Pen, and noncontact tonometers. J Glaucoma [Internet]. 2000 [cited 2022 Sep 27];9(3):219–23. Available from:
  6. Izzotti A, Bagnis A, Saccà SC. The role of oxidative stress in glaucoma. Mutation Research/Reviews in Mutation Research. 2006 Mar 1;612(2):105-14.
  7. Wu H, De Boer JF, Chen L, Chen TC. Correlation of localized glaucomatous visual field defects and spectral domain optical coherence tomography retinal nerve fiber layer thinning using a modified structure–function map for OCT. Eye. 2015 Apr;29(4):525-33.
  8. Sun Y, Chen W, Wang N. [Diagnosis and treatment of ocular hypertension]. Zhonghua Yan Ke Za Zhi [Internet]. 2016 Jul 11 [cited 2022 Sep 27];52(7):542–6. Available from:
  9. Gordon, M. O., Beiser, J. A., Brandt, J. D., Heuer, D. K., Higginbotham, E. J., Johnson, C. A., ... & Ocular Hypertension Treatment Study Group. (2002). The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Archives of ophthalmology, 120(6), 714-720.
  10. Ocular hypertension treatment study (OHTS) calculator [Internet]. [cited 2023 Jun 5]. Available from:
  11. Kwon YH, Fingert JH, Kuehn MH, Alward WLM. Primary Open-Angle Glaucoma. N Engl J Med [Internet]. 2009 Mar 3 [cited 2022 Sep 27];360(11):1113. Available from: /pmc/articles/PMC3700399/
  12. Weinreb RN, Leung CKS, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nature Reviews Disease Primers 2016 2:1 [Internet]. 2016 Sep 22 [cited 2022 Sep 27];2(1):1–19. Available from:
  13. Killer HE, Pircher A. Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis. Eye [Internet]. 2018 May 1 [cited 2022 Sep 27];32(5):924. Available from: /pmc/articles/PMC5944657/
  14. Krishnadas R, Ramakrishnan R. Secondary Glaucomas: The Tasks Ahead. Community Eye Health [Internet]. 2001 [cited 2022 Sep 27];14(39):40. Available from: /pmc/articles/PMC1705934/
  15. Desai, M. A., & Lee, R. K. (2008). The medical and surgical management of pseudoexfoliation glaucoma. International ophthalmology clinics, 48(4), 95.
  16. Ah-Kee EY, Egong E, Shafi A, Lim LT, Yim JL. A review of drug-induced acute angle closure glaucoma for non-ophthalmologists. Qatar Med J [Internet]. 2015 Apr 1 [cited 2022 Sep 27];2015(1). Available from: /pmc/articles/PMC4614311/
  17. Wright C, Tawfik MA, Waisbourd M, Katz LJ. Primary angle-closure glaucoma: an update. Acta Ophthalmol [Internet]. 2016 May 1 [cited 2022 Sep 27];94(3):217–25. Available from:
  18. Rodrigues GB, Abe RY, Zangalli C, Sodre SL, Donini FA, Costa DC, et al. Neovascular glaucoma: A review. Int J Retina Vitreous [Internet]. 2016 Dec 12 [cited 2022 Sep 27];2(1):1–10. Available from:
  19. Robin, A., & Grover, D. S. (2011). Compliance and adherence in glaucoma management. Indian journal of ophthalmology, 59(Suppl1), S93.
  20. Azuara-Blanco, A., Burr, J., Ramsay, C., Cooper, D., Foster, P. J., Friedman, D. S., ... & Norrie, J. (2016). Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. The Lancet, 388(10052), 1389-1397.
  21. He, M., Jiang, Y., Huang, S., Chang, D. S., Munoz, B., Aung, T., ... & Friedman, D. S. (2019). Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial. The Lancet, 393(10181), 1609-1618.


Download data is not yet available.